California 2019-2020 Regular Session

California Assembly Bill AB851

Introduced
2/20/19  
Refer
3/4/19  
Refer
3/4/19  
Report Pass
4/3/19  
Report Pass
4/3/19  
Engrossed
4/11/19  
Engrossed
4/11/19  
Refer
4/11/19  
Refer
4/11/19  
Refer
4/24/19  
Refer
4/24/19  
Report Pass
6/6/19  
Refer
6/6/19  
Refer
6/6/19  
Enrolled
6/20/19  
Enrolled
6/20/19  
Chaptered
7/1/19  

Caption

Drug masking products.

Impact

The legislation updates existing laws concerning the unauthorized use of substances and establishes a clear legal framework surrounding drug masking products. This measure is part of broader initiatives to ensure the integrity of drug testing processes, which are critical for employment screenings, probation, and more. By explicitly prohibiting such products, the bill aims to deter individuals from attempting to manipulate drug tests, thus contributing to the effectiveness of substance abuse prevention and treatment programs.

Summary

Assembly Bill No. 851 aims to implement strict regulations regarding the distribution and sale of drug masking products, which are defined as synthetic urine or other substances used to defraud drug or alcohol screening tests. The bill adds Chapter 1.2 to Division 20 of the Health and Safety Code, specifically targeting those who engage in the sale or possession of such products with the intent to deceive testing measures. By placing these restrictions in California law, the bill seeks to enhance public health efforts and combat substance abuse issues exacerbated by the use of adulterants in drug testing procedures.

Sentiment

Overall, the sentiment surrounding AB 851 appears to be supportive among public health advocates and legislators who prioritize the need for stricter regulations to curb drug abuse. Stakeholders recognize the importance of maintaining the credibility of drug testing as part of broader public health initiatives. However, potential concerns may arise from individuals who oppose governmental restrictions on personal freedoms and argue for more comprehensive approaches to substance abuse that address root causes rather than merely preventing deceitful practices.

Contention

Notable points of contention involve discussions around personal rights and autonomy in regard to how individuals may choose to address drug testing and the potential for unintended consequences. Critics may argue that such bans could disproportionately affect those who use these products for legitimate reasons, such as passing tests related to employment or legal matters. Nevertheless, the consensus among proponents asserts that the legislation is necessary to protect public health and safety by eliminating deceptive practices in drug testing.

Companion Bills

No companion bills found.

Similar Bills

VA SB104

Mandatory minimum sentences; elimination, modification of sentence to mandatory minimum term.

HI SB767

Relating To Cannabis.

MS SB2257

Controlled substance offenses; revise enhanced penalties.

MS SB2248

Controlled substance offenses; revise enhanced penalties.

VA HB179

Imprisonment; consecutive terms.

VA SB888

Imprisonment; consecutive terms.

KS SB238

Increasing criminal penalties on drug-related crimes when the drug is fentanyl and creating special sentencing rules for mandatory imprisonment and additional terms of imprisonment for drug-related crimes when the drug is fentanyl or is attractive to minors because of its appearance or packaging.

SC H3068

Controlled substances, revised forfeiture procedures